Showing results (51-60 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|October 22, 2010
Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909Jürgen Kuball, Karin de Boer, Eva Wagner, et al.Cancer Immunology, Immunotherapy : CII|July 24, 2010
Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particlesSharmila Pejawar-Gaddy, Yogendra Rajawat, Zoe Hilioti, et al.Cancer Immunology, Immunotherapy : CII|July 24, 2010
Efficacy of catumaxomab in tumor spheroid killing is mediated by its trifunctional mode of actionFranziska Hirschhaeuser, Stefan Walenta, Wolfgang Mueller-KlieserCancer Immunology, Immunotherapy : CII|July 17, 2010
A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growthMerete Thune Wiiger, Hege B Gehrken, Øystein Fodstad, et al.Cancer Immunology, Immunotherapy : CII|August 4, 2010
Allogeneic natural killer cells for refractory lymphomaVeronika Bachanova, Linda J Burns, David H McKenna, et al.Cancer Immunology, Immunotherapy : CII|August 14, 2010
Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapyPing Wang, Xiuli Yang, Wei Xu, et al.Cancer Immunology, Immunotherapy : CII|June 26, 2010
CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neckPedro A Andrade Filho, Daisuke Ito, Albert B Deleo, et al.Cancer Immunology, Immunotherapy : CII|June 22, 2010
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumorsJaafar Bennouna, Vincent Levy, Hélène Sicard, et al.Cancer Immunology, Immunotherapy : CII|June 22, 2010
A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancerYuki Masuda, Koichi Ito, Morichika Konishi, et al.Cancer Immunology, Immunotherapy : CII|June 29, 2010
The effect of radiotherapy on NKT cells in patients with advanced head and neck cancerKouichi Kobayashi, Yuriko Tanaka, Shigetoshi Horiguchi, et al.Pageof 650